Watchlists Portfolios Alerts Sign in Get started

Phio Pharmaceuticals Corp. PHIO

Full chart Compare

Set alert

0.82 USD +0.02 (+2.21%)

Nov 9, 2026, 1:03 PM EST

0.7534 Day range 0.82

0.75 52-week range 1.88

YTD: -22.00%
1 year: -47.50%

Discussion (56)

Apextradez PHIO Feb 4, 2025 1 year ago #11

Phio Pharmaceuticals Corp. is scheduled to
present today, February 4, 2025, at
2:00 pm EST during the Renmark
Financial Communications Virtual
Non-Deal Roadshow Series. Robert
Bitterman, the company's CEO and
Chairman, will discuss Phio's
proprietary INTASYL siRNA
technology and the ongoing clinical
trial of their lead compound,
PH-762, aimed at treating skin cancers.